Atlas Trials

First Line Therapy for Patients With Metastatic Breast Cancer

Clinical trial NCT00456846 · TERMINATED

Trial details

NCT number
NCT00456846
Sponsor
Celgene
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2008-02-01
Primary completion
2012-12-11
Enrollment
123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.